| Primary |
| Non-small Cell Lung Cancer |
26.4% |
| Pancreatic Carcinoma |
9.1% |
| Prophylaxis |
9.1% |
| Hypertension |
5.6% |
| Adenocarcinoma Pancreas |
5.5% |
| Pain |
4.7% |
| Non-small Cell Lung Cancer Stage Iv |
4.6% |
| Breast Cancer |
4.5% |
| Pancreatic Carcinoma Metastatic |
4.3% |
| Breast Cancer Metastatic |
3.7% |
| Nausea |
3.6% |
| Transitional Cell Carcinoma |
3.0% |
| Constipation |
2.9% |
| Diabetes Mellitus |
2.5% |
| Product Used For Unknown Indication |
2.1% |
| Non-hodgkin's Lymphoma |
1.8% |
| Pelvic Neoplasm |
1.7% |
| Bladder Cancer |
1.6% |
| Prophylaxis Of Nausea And Vomiting |
1.6% |
| Neoplasm |
1.6% |
|
| Pulmonary Embolism |
10.7% |
| Thrombocytopenia |
9.6% |
| Pneumonia |
8.8% |
| Vomiting |
7.8% |
| Neutropenia |
7.2% |
| Death |
5.7% |
| Dehydration |
5.7% |
| Hepatic Steatosis |
4.7% |
| Sepsis |
4.7% |
| Gastrointestinal Toxicity |
4.5% |
| Interstitial Lung Disease |
4.3% |
| Cholangitis |
3.9% |
| Thrombosis |
3.3% |
| General Physical Health Deterioration |
3.1% |
| Deep Vein Thrombosis |
2.9% |
| Pyrexia |
2.9% |
| Posterior Reversible Encephalopathy Syndrome |
2.7% |
| Neutropenic Sepsis |
2.5% |
| Thrombotic Microangiopathy |
2.5% |
| Febrile Neutropenia |
2.3% |
|
| Secondary |
| Product Used For Unknown Indication |
44.5% |
| Adenocarcinoma Pancreas |
17.6% |
| Non-small Cell Lung Cancer |
7.9% |
| Prophylaxis |
6.2% |
| Pancreatic Carcinoma |
4.4% |
| Diabetes Mellitus |
3.0% |
| Insomnia |
1.8% |
| Hypertension |
1.5% |
| Chemotherapy |
1.3% |
| Transitional Cell Carcinoma |
1.2% |
| Breast Cancer |
1.2% |
| Non-hodgkin's Lymphoma |
1.2% |
| Constipation |
1.2% |
| Pancreatic Carcinoma Metastatic |
1.1% |
| Diarrhoea |
1.1% |
| Nausea |
1.1% |
| Hodgkin's Disease |
1.0% |
| Adenocarcinoma |
0.9% |
| Pain |
0.9% |
| Cancer Pain |
0.8% |
|
| White Blood Cell Count Decreased |
23.2% |
| Rash |
15.6% |
| Platelet Count Decreased |
5.8% |
| Cholecystitis Acute |
4.6% |
| Interstitial Lung Disease |
4.2% |
| Neutrophil Count Decreased |
4.2% |
| Pyrexia |
4.2% |
| Stomatitis |
4.1% |
| Anaemia |
3.7% |
| Death |
3.4% |
| Malignant Neoplasm Progression |
3.2% |
| Neutropenia |
3.2% |
| Thrombocytopenia |
3.2% |
| Vomiting |
3.0% |
| Cholangitis |
2.7% |
| Blood Bilirubin Increased |
2.5% |
| Skin Disorder |
2.5% |
| Pneumonia |
2.3% |
| Ulcerative Keratitis |
2.3% |
| Diarrhoea |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
48.7% |
| Adenocarcinoma Pancreas |
21.6% |
| Pancreatic Carcinoma |
8.3% |
| Pain |
2.7% |
| Non-small Cell Lung Cancer |
2.5% |
| Breast Cancer Metastatic |
2.5% |
| Small Intestine Carcinoma |
2.0% |
| Diffuse Large B-cell Lymphoma |
1.7% |
| Prophylaxis |
1.6% |
| Lung Adenocarcinoma Recurrent |
1.3% |
| Breast Cancer |
1.1% |
| Pancreatic Carcinoma Non-resectable |
0.9% |
| Hypertension |
0.8% |
| Ovarian Cancer |
0.8% |
| Pancreatic Carcinoma Stage Iv |
0.8% |
| Metastatic Renal Cell Carcinoma |
0.7% |
| Bile Duct Cancer |
0.6% |
| Transitional Cell Carcinoma |
0.6% |
| Brain Oedema |
0.5% |
| Candida Infection |
0.4% |
|
| Intra-abdominal Haemorrhage |
14.0% |
| Rash |
12.4% |
| Decubitus Ulcer |
10.1% |
| Skin Disorder |
9.6% |
| Vomiting |
7.9% |
| Pulmonary Embolism |
7.3% |
| Decreased Appetite |
6.2% |
| Proteinuria |
5.1% |
| Disseminated Intravascular Coagulation |
3.4% |
| Anaemia |
2.8% |
| Nausea |
2.8% |
| Neoplasm Malignant |
2.8% |
| White Blood Cell Count Increased |
2.8% |
| Cholangitis |
2.2% |
| Dermatitis Acneiform |
2.2% |
| Deep Vein Thrombosis |
1.7% |
| Drug Level Increased |
1.7% |
| Malignant Pleural Effusion |
1.7% |
| Off Label Use |
1.7% |
| Platelet Count Increased |
1.7% |
|
